Publications

Chapters and manuals

• Pink Book’s chapter on Haemophilus influenzae type b
• Surveillance Manual’s chapter on Haemophilus influenzae type b
• Manual on Laboratory Methods for the Diagnosis of Meningitis

Articles

Vaccine recommendations and licensures

View all current and historical Hib vaccine recommendations from the Advisory Committee for Immunization Practices. Current recommendations are also listed below:

• CDC. Licensure of a diphtheria and tetanus toxoids and acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b conjugate, and hepatitis B vaccine, and guidance for use in infants. MMWR Morb Mortal Wkly Rep. 2020;69(5):136–139.
• CDC. Food and Drug Administration approval for use of Hiberix as 3-dose primary Haemophilus influenzae type b (Hib) vaccination series. MMWR Morb Mortal Wkly Rep. 2016;65(16):418–9.
• CDC. Prevention and control of Haemophilus influenzae type b disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2014;63(RR01);1–14.

Surveillance, epidemiology and outbreaks

• Nolen LD, DeByle C, Topaz N, et al. Genomic diversity of Haemophilus influenzae serotype a in an outbreak community—Alaska, 2018external icon. J Infect Dis. 2022;225(3):520–4.
• Bozio CH, Blain A, Edge K, et al. Clinical characteristics and adverse clinical outcomes of invasive Haemophilus influenzae serotype a cases—United States, 2011–2015external icon. Clin Infect Dis. 2021;73(11):e3670–6.
• Brown NE, Blain AE, Burzlaff K, et al. Racial disparities in invasive Haemophilus influenzae disease—United States, 2008–2017external icon. Clin Infect Dis. 2021;73(9):1617–24.
• Soeters HM, Oliver SE, Plumb ID, et al. Epidemiology of invasive Haemophilus influenzae serotype a disease—United States, 2008–2017external icon. Clin Infect Dis. 2021;73(2):e371–9.
• Collins LF, Havers FP, Tunali A, et al. Invasive nontypeable Haemophilus influenzae infection among HIV-positive individuals in metropolitan Atlanta, 2008–2018external icon. JAMA. 2019;322(24):2399–410.
• Tsang RS, Bruce MG, Lem M, Barreto L, Ulanova M. A review of invasive Haemophilus influenzae disease in the Indigenous populations of North Americaexternal icon. Epidemiol Infect. 2014;142(7):1344–54.
• Nix EB, Williams K, Cox AD, et al. Naturally acquired antibodies against Haemophilus influenzae type a in aboriginal adults, Canada. Emerg Infect Dis. 2015;21:273–9.
• Blain A, MacNeil J, Wang X, et al. Invasive Haemophilus influenzae disease in adults ≥ 65 years, United States, 2011external icon. Open Forum Infect Dis. 2014;1:1–5.
• Hajjeh R, Mulholland K, Schuchat A, Santosham M. Progress towards demonstrating the impact of Haemophilus influenzae type b vaccines globallyexternal icon. J Pediatr. 2013;163(1 Suppl):S1–3.
• Livorsi DJ, MacNeil JR, Cohn AC, et al. Invasive Haemophilus influenzae in the United States, 1999–2008: Epidemiology and outcomesexternal icon. J Infect. 2012;65:496–504.
• Rose CE, Cohn A, Coronado F, et al. Modeling insights into Haemophilus influenzae type b disease, transmission, and vaccine programs. Emerg Infect Dis. 2012;18:13–20.
• Lowther SA, Shinoda N, Juni BA, et al. Haemophilus influenzae type b infection, vaccination, and H. influenzae carriage in children in Minnesota, 2008–2009external icon. Epidemiol Infect. 2012;140:566–74.
• Briere EC, Jackson M, Shah SG, et al. Haemophilus influenzae type b disease and vaccine booster dose deferral, United States, 1998–2009external icon. Pediatrics. 2012;130:414–20.
• MacNeil JR, Cohn AC, Farley M, et al. Current epidemiology and trends in invasive Haemophilus influenzae disease—United States, 1989–2008external icon. Clin Infect Dis. 2011;53:1230–6.
• Rubach MP, Bender JM, Mottice S, et al. Increasing incidence of invasive Haemophilus influenzae disease in adults, Utah, USA. Emerg Infect Dis. 2011;17:1645–50.
• CDC. Invasive Haemophilus influenzae type b disease in five young children — Minnesota, 2008. MMWR Morb Mortal Wkly Rep. 2009;58(early release):1–3.

Laboratory

• Buono SA, Kelly RJ, Topaz N, et al. Web-based genome analysis of bacterial meningitis pathogens for public health applications using the Bacterial Meningitis Genomic Analysis Platform (BMGAP)external icon. Front Genet. 2020;11:601870.
• Potts CC, Topaz N, et al. Genomic characterization of Haemophilus influenzae: a focus on the capsule locus.external icon BMC Genomics. 2019;20(1):733.
• Wu HM, Cordeiro SM, Harcourt BH, et al. Accuracy of real-time PCR, Gram stain and culture for Streptococcus pneumoniae, Neisseria meningitidis and Haemophilus influenzae meningitis diagnosisexternal icon. BMC Infect Dis. 2013;22:13:26.
• Theodore M, Anderson R, Wang X, et al. Evaluation of new biomarker genes for differentiating Haemophilus influenzae from Haemophilus haemolyticusexternal icon. J Clin Microbiol. 2012;50:1422–4.
• Wang X, Mair RM, Hatcher CP, et al. Detection of bacterial pathogens in Mongolia meningitis surveillance with a new real-time PCR assay to detect Haemophilus influenzaeexternal icon. Int J Med Microbiol. 2011;301:303–9.